| Manufacturer | Pfizer | Merck Serono / EMD Serono | Sandoz | Novo Nordisk |
|---|
| Reference country, presentation and label | Canadian GoQuick 5.3 mg; Pfizer monograph revised July 28, 2020 [G] | Canadian 6 mg liquid cartridge; EMD Serono monograph revised June 8, 2020 [S] | U.S. 10 mg/1.5 mL liquid cartridge; FDA labeling, 2025 [O] | U.S. FlexPro 10 mg/1.5 mL pen; Novo Nordisk PI revised January 2026 [N] |
|---|
| Total somatropin: mg and IU context | 5.3 mg; approximately 15.9 IU at 3 IU/mg. The photographed carton marks 16 UI. | 6 mg; approximately 18 IU at 3 IU/mg. | 10 mg; approximately 30 IU at 3 IU/mg. | 10 mg; approximately 30 IU at 3 IU/mg. |
|---|
| Somatropin concentration | 5.3 mg/mL after reconstitution. | 5.83 mg/mL. | Approximately 6.67 mg/mL, calculated from the labeled 10 mg/1.5 mL. | Approximately 6.67 mg/mL, calculated from the labeled 10 mg/1.5 mL. |
|---|
| Documented liquid volume / fill information | Composition is specified per 1 mL. The Canadian GoQuick container description states 1.14 mL supplied liquid; that is not the same measure as a declared deliverable volume. | 1.03 mL liquid fill. The nominal glass-cartridge capacity is 3 mL, not the amount of liquid supplied. | 1.5 mL. | 1.5 mL. |
|---|
| Preservative type | Metacresol (m-cresol). | Phenol. | Phenol in this 10 mg cartridge. The U.S. 5 mg cartridge instead uses benzyl alcohol. | Phenol. |
|---|
| Documented preservative quantity | 3 mg/mL in the reconstituted Canadian GoQuick formulation. | 3.8 mg per 6 mg cartridge in the cited Canadian monograph. | 4.5 mg phenol per 1.5 mL cartridge, equivalent to 3 mg/mL. | 4.5 mg per 1.5 mL pen, equivalent to 3 mg/mL. |
|---|
| Other inactive ingredients and stabilizers | Glycine, mannitol, sodium dihydrogen phosphate, disodium phosphate and water for injection. | Sucrose, poloxamer 188, citric acid, sodium hydroxide for pH adjustment, and water for injection. | Glycine, sodium phosphate buffers, poloxamer and water for injection; sodium hydroxide/phosphoric acid may adjust cartridge pH. | Histidine, mannitol, poloxamer 188, hydrochloric acid/sodium hydroxide as needed for pH adjustment, and water for injection. |
|---|
| Delivery system | Disposable multidose GoQuick pen containing a two-chamber powder-and-solvent cartridge. | Ready-to-use liquid cartridge for a compatible reusable injector. | Ready-to-use liquid cartridge with a reusable injector. | Integrated disposable prefilled FlexPro pen containing ready-to-use liquid. |
|---|
| Reconstitution | Required. A prefilled powder-and-solvent pen is not a ready-to-use liquid pen. | Not required for the specified liquid cartridge. Historical powder/vial presentations are separate. | Not required for this liquid cartridge; the U.S. 5.8 mg powder vial requires reconstitution. | Not required. |
|---|
| Cartridge and injector compatibility | GoQuick is an integrated disposable system. The separate UK 5.3 mg cartridge uses its matching blue Genotropin Pen 5.3; U.S. Pen 5 is a distinct 5 mg system. | The cited Canadian/UK liquid-cartridge labeling identifies easypod or matching aluetta systems. UK aluetta 6 is blue, aluetta 12 red and aluetta 20 yellow. | U.S. 10 mg/1.5 mL cartridge: Omnitrope Pen 10. The U.S. 5 mg cartridge uses Pen 5. European SurePal cartridge systems have their own matching devices. | Use the integrated labeled FlexPro pen and its specified accessories. It does not accept another brand’s cartridge. NordiFlex is a separately named pen system. |
|---|
| Unopened storage | Canadian GoQuick: refrigerate at 2–8°C until expiry, or up to 4 weeks at ≤25°C before reconstitution. During/after that unrefrigerated period, do not return the unreconstituted product to refrigeration. | Refrigerate at 2–8°C in the original package; do not freeze. | Refrigerate at 2–8°C in the original carton; do not freeze. | Refrigerate at 2–8°C until the printed expiry; do not freeze; protect from light. |
|---|
| In-use storage | After reconstitution, refrigerate at 2–8°C and protect from light; do not freeze or shake. | 28 days total at 2–8°C, of which no more than 7 days may be at ≤25°C; keep the cartridge in the specified device and return it to refrigeration. | Keep the cartridge in its specified pen, refrigerated at 2–8°C and protected from light. | Either refrigerate at 2–8°C for up to 4 weeks, or store at ≤25°C for up to 3 weeks. |
|---|
| In-use shelf life | 4 weeks after reconstitution under the Canadian labeled storage conditions. | Discard after 28 days, or if the total permitted unrefrigerated period exceeds 7 days. | 28 days after first use for the specified U.S. cartridges; the separate U.S. powder vial has a 21-day rule after reconstitution. | 4 weeks refrigerated OR 3 weeks at the labeled room-temperature limit; these are alternatives, not additive periods. |
|---|
| Important formulation differences | Powder plus solvent; metacresol-preserved multidose formulation. MiniQuick is a separate preservative-free single-dose presentation. | Sucrose-containing liquid formulation. The 12 mg and 20 mg cartridges have different concentrations/fill volumes from the 6 mg cartridge. | Preservative and stabilizer vary by strength: U.S. 5 mg has benzyl alcohol/mannitol; 10 mg has phenol/glycine. | Prefilled liquid with histidine/mannitol/poloxamer. The U.S. 15 mg pen has different histidine/mannitol quantities from the 5 mg and 10 mg pens. |
|---|
| Practical advantages | Integrated GoQuick avoids replacing cartridges in a reusable injector; preparation is still required. | Ready-to-use cartridge; a choice of labeled compatible injection systems. | Reusable injector with replaceable ready-to-use cartridges. | No reconstitution or separate reusable cartridge loading for the specified FlexPro presentation. |
|---|
| Limitations and considerations | Match the exact country, strength and device. The international 5.3 mg pack and U.S. 5 mg cartridge are not identical product listings. | Cartridge capacity does not establish fill volume. click.easy belongs to a different historical powder presentation, not a universal Saizen cartridge system. | Select the cartridge for its matching injector. A 15 mg international cartridge is not automatically compatible with a U.S. Pen 10. | Do not infer equivalent pen mechanics, formulation quantities or market authorization from the Norditropin name alone. |
|---|